Imagine you’re a startup founder, pouring everything into a breakthrough gadget. You’ve sued an infringer, settled quick—standard move, since 95% of patent cases end that way. Now, under the proposed STRONGER Patents Act, does that handshake deal lock out challengers from gutting your patent at the Patent Office? For real people grinding in garages and labs, this bill’s fuzziness means the difference between building an empire or watching it evaporate in review proceedings.
Here’s the thing. The STRONGER Patents Act—Senate Bill 2082, House Resolution 3666—aims to toughen patents against inter partes review (IPR) and post-grant review (PGR). It wants federal court calls on validity to trump PTAB challenges. But drill into sections 102(h) and 103(h), and cracks appear wide enough for abuse.
Does a Settlement Judgment “Decide” Validity?
Overwhelmingly, patent cases resolve in settlement and entry of agreed judgments, and it is not uncommon for such agreed judgments to include acknowledgments of patent validity. Would such cases operate to bar or terminate IPR or PGR under the STRONGER Patents Act?
That’s the opener from patent pros dissecting the bill. Spot on. Data from PwC shows 90-95% of district court patent suits settle before trial. Toss in ITC cases—another 80% settle—and you’ve got a system where “final judgments” are often stipulated nods, not epic battles.
But does nodding along count as “deciding” validity under 35 U.S.C. §§ 102 or 103? The bill says a court must enter a final judgment that “decides the validity.” Vague. Challengers fail to prove invalidity (thanks to presumption of validity), so judgments often just say “not proven invalid.” Not the same as “valid.”
Settlements? They might stipulate validity to wrap things up. Patent trolls love this—pay up, acknowledge validity, then wave the judgment to block IPRs forever. Real innovators? Stuck if challengers dodge settlement and hit PTAB first.
And here’s my take, absent from the original chatter: this echoes the America Invents Act’s early days. Back in 2012, vague estoppel rules let serial challengers game multiple bites. STRONGER risks the same—shielding weak patents more than strong ones, bloating troll portfolios. Market data backs it: PTAB invalidates ~70% of challenged claims; dialing that back without clarity hands use to non-practicing entities, who hold 60% of litigated patents per Unified Patents.
Why Does a Federal Court Win Matter More Than PTAB?
The bill flips eBay v. MercExchange, easing injunctions. Petitioners must show invalidity by clear and convincing evidence—up from preponderance. One bite per claim. Solid reforms, if you buy the narrative that PTAB guts U.S. innovation.
Proponents cite stats: 84% of district court patents survive validity fights, vs. PTAB’s 65% kill rate. But correlation ain’t causation. PTAB sees weaker patents—litigants filter the strong ones to court. Plus, PTAB’s broader prior art pool (no §102(b) limit pre-AIA) explains discrepancies.
Sections 102(h) and 103(h) prioritize courts and ITC: no IPR/PGR institution post-final judgment on anticipation/obviousness; stay ongoing ones, terminate if upheld. Appealable or exhausted appeals only.
Problem? Bill doesn’t say if it blocks all grounds or just those litigated. Other sections estop on raised/raiseable grounds—but not here. Intent seems total bar, yet text limits to §§102/103. Sloppy drafting invites fights.
Look, inventors cheer less PTAB harassment—filings spiked 400% post-AIA, crushing small players’ enforcement odds. But without nailing “decides,” big tech (Apple, Google) keeps IPR hammer; trolls exploit settlements. Net? Stifled licensing markets, down 20% since 2012 per RPX data.
My bold call: this passes fragmented, neutered. Like 2015/2017 versions, it dies in conference—too pro-patent for Dems, not enough for GOP holdouts. Meanwhile, real people patent less; USPTO grants fell 15% YoY.
What About ITC Rulings and Ongoing Appeals?
ITC exclusion orders pack punch—import bans sting multinationals. Bill folds them in, staying PTAB if appeal pending, terminating on uphold.
Edge case: partial judgments. Court upholds some claims, tosses others? Bill says “patent claim,” singular. Per-claim? Chaos.
Affirmative validity needed? Bill says “decides the validity.” Challengers lose = not invalid ≠ valid. Presumption holds, but trolls stipulate “valid” routinely.
Data point: 25% of settlements include validity nods, per Lex Machina. If those bar IPR, trolls multiply—NPE suits up 50% last decade.
Skeptical? Damn right. Bill’s PR spins as innovation savior, but vagueness favors gamesters. Fix it: define “decides” as merits adjudication, affirmative validity, matching grounds. Otherwise, it’s half-measure hurting the little guy it claims to help.
🧬 Related Insights
- Read more: Can OpenAI’s Shaky Guardrails Hold Up in the Pentagon’s Crosshairs?
- Read more: How AI Companies Became Weapons Manufacturers—And Why It’s a Legal Reckoning
Frequently Asked Questions
What is the STRONGER Patents Act?
It’s a 2019 bill (S.2082/H.R.3666) to strengthen patents by limiting IPR/PGR after court validity rulings, easing injunctions, and hiking petitioner burdens.
Does STRONGER Patents Act block IPR after settlements?
Unclear—the bill’s “final judgment that decides validity” might include stipulated settlements, but likely needs merits decision. Expect litigation to clarify.
Will STRONGER Patents Act pass Congress?
Doubtful; prior versions stalled. Bipartisan patent reform fights persist, with Big Tech vs. pharma/biotech lobbies.
